Taro Pharmaceutical Industries Ltd (TARO)
42.40
-0.08
(-0.19%)
USD |
NYSE |
Apr 26, 16:00
42.41
+0.01
(+0.02%)
After-Hours: 20:00
Taro Pharmaceutical Industries Cash from Investing (Quarterly): 81.67M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 81.67M |
| September 30, 2023 | 98.57M |
| June 30, 2023 | -38.70M |
| March 31, 2023 | 6.674M |
| December 31, 2022 | -96.19M |
| September 30, 2022 | -70.79M |
| June 30, 2022 | 34.76M |
| March 31, 2022 | -108.61M |
| December 31, 2021 | -14.02M |
| September 30, 2021 | -31.53M |
| June 30, 2021 | -16.43M |
| March 31, 2021 | 21.95M |
| December 31, 2020 | 13.00M |
| September 30, 2020 | 78.81M |
| June 30, 2020 | -46.02M |
| March 31, 2020 | -44.40M |
| December 31, 2019 | -123.62M |
| September 30, 2019 | -113.07M |
| June 30, 2019 | -17.07M |
| March 31, 2019 | -41.60M |
| December 31, 2018 | 174.84M |
| September 30, 2018 | 115.64M |
| June 30, 2018 | 8.263M |
| March 31, 2018 | -37.33M |
| December 31, 2017 | -6.732M |
| Date | Value |
|---|---|
| September 30, 2017 | 37.22M |
| June 30, 2017 | -234.80M |
| March 31, 2017 | -41.69M |
| December 31, 2016 | 86.54M |
| September 30, 2016 | -100.76M |
| June 30, 2016 | -61.86M |
| March 31, 2016 | -97.10M |
| December 31, 2015 | -67.36M |
| September 30, 2015 | -5.723M |
| June 30, 2015 | -114.55M |
| March 31, 2015 | 12.96M |
| December 31, 2014 | -60.10M |
| September 30, 2014 | -114.33M |
| June 30, 2014 | 69.39M |
| March 31, 2014 | -77.97M |
| December 31, 2013 | -49.95M |
| September 30, 2013 | -21.14M |
| June 30, 2013 | -24.23M |
| March 31, 2013 | -113.63M |
| December 31, 2012 | -92.63M |
| September 30, 2012 | 30.45M |
| June 30, 2012 | -68.12M |
| December 31, 2011 | -64.14M |
| September 30, 2011 | -4.236M |
| June 30, 2011 | -0.966M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-123.62M
Minimum
Dec 2019
98.57M
Maximum
Sep 2023
-20.26M
Average
-17.07M
Median
Jun 2019
Cash from Investing (Quarterly) Benchmarks
| InspireMD Inc | -0.036M |
| BiomX Inc | -0.006M |
| Alpha Tau Medical Ltd | -- |
| Pluri Inc | 3.919M |
| Raphael Pharmaceutical Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 30.92M |
| Free Cash Flow | 86.00M |
| Free Cash Flow Per Share (Quarterly) | -0.0945 |
| Free Cash Flow to Equity (Quarterly) | -3.553M |
| Free Cash Flow to Firm (Quarterly) | -3.553M |
| Free Cash Flow Yield | 5.40% |